跳至主要内容
临床试验/NCT02920216
NCT02920216已完成不适用

Pilot Study of Evaluation of the Interest of Fluorescence in Salvage Surgery for Recurrence of Head and Neck Cancer in Irradiated Area

Institut de Cancérologie de Lorraine1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2016年12月6日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
10
试验地点
1
主要终点
Sensitivity of indocyanine green labeling in Irradiated Area

研究概览

简要总结

Treatment of Head and Neck Squamous cell carcinoma often combines chemoradiotherapy when organ has to be preserved or when surgery is not indicated. The loco-regional failure is about 30%. Then salvage surgery is the only chance for patients to survive but the overall survival rate is only 29% at 24 months. This prognostic is bad because of poor local control which is non-optimized by a complementary radiotherapy and negative exeresis margins.

Currently, there is no intraoperative technique to better visualize the tumor limits in real time. With fluorescence techniques, an accurate mapping of tumor extension can be considered. Recently, Atallah et al. (2015) demonstrated the use of fluorescence during a head and neck surgery in mice, as a tool allowing for better surgical margins. Digonnet et al (2015) found a tumor fragment after an injection of indocyanine green (ICG) intravenously in salvage surgery for patient with head and neck cancer.

The ability of ICG to detect a surgical margin positive intraoperatively has never be evaluated in irradiated area.

The aim of this pilot study is to evaluate the interest of fluorescence in salvage surgery for recurrence of head and neck cancer in irradiated area.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient over 18 years old
  • Head and Neck Squamous Cell Carcinoma confirmed by biopsy
  • Non metastatic disease
  • Resectable tumour
  • Locoregional recurrence or new localization in pre irradiated territory at a dose ≥ 50 Gy with or without chemotherapy
  • Haematological constants, liver function and kidney function adapted in the 15 days before inclusion:
  • Haemoglobin ≥ 9 g / dL
  • Polymorphonuclear neutrophils ≥ 1.5 x 10 9
  • Platelet ≥ 100 x 109 / L
  • Total bilirubin ≤ 1.5 times upper limit of normal (ULN)
  • ALT and AST <3 times ULN
  • Alkaline phosphatase ≤ 2.5 times ULN
  • Serum creatinine <110 mmol / L or creatinine clearance> 55 ml / min (method of Cockcroft)
  • Absence of proteinuria
  • WHO 0 or 1
  • Signed informed consent form
  • Patient affiliated to the social security system.

排除标准

  • Patient considered as non eligible for a salvage surgery
  • Metastatic disease
  • Hypersensitivity to indocyanine green or allergy to seafood or reaction to iodinated contrast agents
  • Pregnant or breastfeeding women

研究组 & 干预措施

eligible patient for a salvage surgery

Experimental

干预措施: indocyanine green (Drug)

结局指标

主要结局

Sensitivity of indocyanine green labeling in Irradiated Area

时间窗: 1 day

The indocyanine green labeling in irradiated areas will be compared to the histological result on the surgical specimen.

次要结局

  • Sensitivity of indocyanine green labeling on surgical margins(1 day)

研究者

发起方
Institut de Cancérologie de Lorraine
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验